Vincent Gardès

Vincent Gardès

Président chez THERACLION
Health Technology
Finance
Consumer Services

Profil

Vincent Gardès currently works at Amber Implants, as Chief Executive Officer from 2025, Théraclion SA, as Chairman from 2026, and Truffle Capital SAS, as Senior Partner from 2018.
Mr. Gardès also formerly worked at Vexim SA, as Chief Executive Officer & Director from 2015 to 2018, Germitec SA, as Chief Executive Officer & Director, Affluent Medical SA, as Chairman from 2018 to 2020, CR Bard (Spain), as Managing Director, Stryker Spine SAS, as Product Manager, Stryker Orthopaedics Corp., as Product Manager, Medtronic France SAS, as Manager-Business Unit from 2002 to 2007, and Stryker Spain Holding SL, as Manager-Sales & Marketing from 1996 to 1999.
Mr. Gardès received his undergraduate degree from Institut Des Etudes Economiques Et Commerciales.

Postes actifs de Vincent Gardès

SociétésPosteDébut
THERACLION Président 08/07/2026
Private Equity Investor 01/09/2018
Directeur Général 06/11/2025

Anciens postes connus de Vincent Gardès

SociétésPosteFin
Président 01/05/2020
VEXIM Directeur Général 31/05/2018
Corporate Officer/Principal 01/09/2007
Corporate Officer/Principal 01/01/2002
Sales & Marketing 01/01/1999
Voir l'expérience en détail de Vincent Gardès

Formation de Vincent Gardès

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Commercial Services

Health Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Vincent Gardès